Clinical Trials Directory

Trials / Unknown

UnknownNCT02788383

Fetal RhD Genotye Non Invasive Prenatal Determination

Aplicación en la práctica clínica de la determinación Prenatal no Invasiva en el Genotipo RhD Fetal Durante el Primer Trimestre de la gestación en Gestantes RhD Negativas

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Academic / Other
Sex
Female
Age
Healthy volunteers
Accepted

Summary

Actually, our center is doing the prenatal determination of RhD fetal genotype in all RhD negative pregnant women. The investigator want to demonstrate that this is an useful and efficient method.

Detailed description

This is a retrospective observational study that pretend to demonstrate that the prenatal determination of RhD fetal genotype is useful and efficient in our clinical practice. I'm going to check the clinical history of all negative RhD pregnant women since January 2013 until December 2015. I'll check if prenatal determination matches with postnatal RhD determination of newborn. Usually, when a RhD negative woman is pregnant we administrate gammaglobulin in 28 gestation weeks, after invasive procedures and after delivery if the baby is positive RhD. Althought, the investigators know that the 40 percent of RhD negative pregnant have a negative RhD baby. This study will do posible to know how many gammaglobulins hasn't been necessary thanks to prenatal determination. This is an important thing because gammaglobulin is an humanoid product ( it isn't without heatlth risks,...) and because is expensive. For this reason, if the investigators do universal determination of RhD fetal genotype the investigators can avoid the administration of humanoid product in pregnant women. I want to demonstrate that this practice is very useful and efficient in our population.

Conditions

Timeline

Start date
2016-06-01
Primary completion
2016-12-01
First posted
2016-06-02
Last updated
2016-06-22

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT02788383. Inclusion in this directory is not an endorsement.

Fetal RhD Genotye Non Invasive Prenatal Determination (NCT02788383) · Clinical Trials Directory